Status:
WITHDRAWN
LALAK for Opacities
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Eye Institute (NEI)
Conditions:
STROMAL OPACITIES
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this protocol is to compare and develop new surgical technique of partial-thickness corneal transplantation for treating corneal opacity. A newly developed technique, "dovetail" laser-a...
Eligibility Criteria
Inclusion
- Eyes with corneal opacities that cannot be adequately or safely corrected with spectacles, contact lens or excimer laser surface ablation. The cornea must have healthy endothelium (endothelial cell density \> 1,500/mm2).
Exclusion
- Preoperative corneal thickness less than 400 microns.
- Inability to give informed consent.
- Corneal edema
- Central guttata
- Inability to maintain stable fixation for OCT imaging.
- Inability to commit to required visits to complete the study.
- Eyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery.
- Patients with severe collagen vascular diseases or ocular surface disorders
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01901601
Start Date
July 1 2013
End Date
August 31 2017
Last Update
April 6 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.